Jubilee Metals Group plc (LON:JLP) CEO Leon Coetzer joins DirectorsTalk Interviews to discuss the performance of its operations and progress on growth projects for the six-month period to 30th June 2022. Leon
Chesnara plc (LON: CSN) is the topic of conversation when Dr Brian Moretta, Analyst at Hardman & Co joins DirectorsTalk Interviews. Brian discusses its recent acquisition in the Netherlands, a life
Shield Therapeutics plc (LON:STX) is the topic of conversation when Hardman & Co Analyst Dr Martin Hall joins DirectorsTalk Interviews. Despite launching a drug into the US market, Shield has performed
Touchstone Exploration (LON:TXP) CEO Paul Baay joins DirectorsTalk Interviews to discuss the Environmental Impact Assessment. Now that the Environmental Management Authority have confirmed that the Environmental Impact Assessment is complete Paul
Fidelity Special Values (LON:FSV) is the topic of conversation when Dr Brian Moretta, Analyst at Hardman & Co joins DirectorsTalk Interviews to discuss a report on the company entitled ‘Inflation causes
Tissue Regenix Group plc (LON:TRX) is the topic of conversation when Dr Martin Hall joins DirectorsTalk Interviews. Martin reminds us of what the company does, summerises the key details from its
Renold plc (LON:RNO) CEO Robert Purcell joins DirectorsTalk Interviews to discuss the acquisition of Industrias YUK S.A. Robert explains what the company does, what it brings to the company, the synergies
Biome Technologies plc (LON:BIOM) CEO Paul Mines joins DirectorsTalk to discuss a trading update for the quarter ended 30th June 2022. Paul explains why revenues were slightly lower than management expectations at
Symphony Environmental Technologies plc (LON:SYM) CFO Ian Bristow joins DirectorsTalk Interviews to discuss its trading update for the six months ended 30th June 2022. Ian talks us through the key financial
Zinc Media Group plc (LON: ZIN), an award-winning television, brand and audio production Group has today announced that it has conditionally agreed to acquire the entire issued and to be issued
© 2022 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
